Abstract

Hypospadias, characterized by misplacement of the urinary meatus in the lower side of the penis, is a frequent birth defect in male children. Because of the huge variation in the anatomic presentation of hypospadias, no single urethroplasty procedure is suitable for all situations. Hence, many surgical techniques have emerged to address the shortage of tissues required to bridge the gap in the urethra particularly in the severe forms of hypospadias. However, the rate of postoperative complications of currently available surgical procedures reaches up to one-fourth of the patients having severe hypospadias. Moreover, these urethroplasty techniques are technically demanding and require considerable surgical experience. These limitations have fueled the development of novel tissue engineering techniques that aim to simplify the surgical procedures and to reduce the rate of complications. Several types of biomaterials have been considered for urethral repair, including synthetic and natural polymers, which in some cases have been seeded with cells prior to implantation. These methods have been tested in preclinical and clinical studies, with variable degrees of success. This review describes the different urethral tissue engineering methodologies, with focus on the approaches used for the treatment of hypospadias. At present, despite many significant advances, the search for a suitable tissue engineering approach for use in routine clinical applications continues.

Highlights

  • Hypospadias is a frequent genitourinary congenital malformation with an incidence of around 1 per 300 male newborns, its frequency varies among populations from 0.3 to 7.0 per 1,000 live births [1, 2]

  • We summarize the limitations of the current surgical management of severe hypospadias and examine the recent tissue engineering developments toward repair of the urethra, with special focus on the research targeted to severe hypospadias in children

  • Current urethroplasty techniques for the management of severe hypospadias are associated with significant morbidities and limitations that strongly mandates the need to “think outside the box.”

Read more

Summary

Current Status of Tissue Engineering in the Management of Severe Hypospadias

The rate of postoperative complications of currently available surgical procedures reaches up to one-fourth of the patients having severe hypospadias. These urethroplasty techniques are technically demanding and require considerable surgical experience. These limitations have fueled the development of novel tissue engineering techniques that aim to simplify the surgical procedures and to reduce the rate of complications. Several types of biomaterials have been considered for urethral repair, including synthetic and natural polymers, which in some cases have been seeded with cells prior to implantation These methods have been tested in preclinical and clinical studies, with variable degrees of success.

INTRODUCTION
CURRENT MANAGEMENT OF SEVERE HYPOSPADIAS AND ITS LIMITATIONS
THE RISE OF URETHRAL TISSUE ENGINEERING
FABRICATION AND ADDITION OF BIOACTIVE FACTORS
URETHRAL REPLACEMENT
PGA and PLGA
CONCLUSION AND FUTURE DIRECTIONS
AUTHOR CONTRIBUTIONS

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.